Fill Out Your Profile to share more about you. Learn more...

Enhertu Improves Survival in People With HER2-Low MBC

Options
moderators
moderators Posts: 8,285

A New Standard of Care? Enhertu Improves Survival in People With Metastatic HER2-Low Breast Cancer
June 6, 2022

Compared with doctors' choice of chemotherapy, Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) improved both progression-free survival and overall survival in people diagnosed with previously treated metastatic HER2-low breast cancer. Read more...